During the past decade, Wojskowy Instytut Medyczny, Centralny Szpital Kliniczny MON conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojskowy Instytut Medyczny, Centralny Szpital Kliniczny MON" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored, "Celgene" with 1 trials sponsored, "Cubist Pharmaceuticals LLC" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojskowy Instytut Medyczny, Centralny Szpital Kliniczny MON" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Population Health Research Institute" with 1 trials as a collaborator and "Vanderbilt University Medical Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Wojskowy Instytut Medyczny, Centralny Szpital Kliniczny MON" are "Multiple Sclerosis" (3 trials), "Bladder Cancer" (2 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Bloodloss" (1 trials) and "Myocardial Injury After Noncardiac Surgery (MINS)" (1 trials). Many other conditions were trialed in "Wojskowy Instytut Medyczny, Centralny Szpital Kliniczny MON" in a lesser frequency.

Most popular intervention types in "Wojskowy Instytut Medyczny, Centralny Szpital Kliniczny MON" are "Drug" (11 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (4 trials), "Placebo" (4 trials), "Antihistamine" (2 trials), "Apaziquone" (2 trials) and "Methylprednisolone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wojskowy Instytut Medyczny, Centralny Szpital Kliniczny MON" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Wojskowy Instytut Medyczny, Centralny Szpital Kliniczny MON". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Wojskowy Instytut Medyczny, Centralny Szpital Kliniczny MON, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Wojskowy Instytut Medyczny, Centralny Szpital Kliniczny MON, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".